The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation

Ítems similars

• Assessing the Optimum Use of Androgen-Deprivation Therapy in High-Risk Prostate Cancer Patients Undergoing External Beam Radiation Therapy
  per: Ludwig, Michelle S., et al.
  Publicat: (2016)
• Early Biochemical Predictors of Survival in Intermediate and High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy
  per: Patel, Mira A., et al.
  Publicat: (2019)
• Dose escalation using ultra-high dose IMRT in intermediate risk prostate cancer without androgen deprivation therapy: preliminary results of toxicity and biochemical control
  per: Petrongari, Maria Grazia, et al.
  Publicat: (2013)
• Timing of Biochemical Failure and Distant Metastasis for Low, Intermediate, and High Risk Prostate Cancer after Radiotherapy
  per: Morgan, Peter B., et al.
  Publicat: (2007)
• Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?
  per: Shakespeare, Thomas P, et al.
  Publicat: (2016)